Ironsides Asset Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-21,164
Closed -$1.19M 123
2016
Q4
$1.19M Sell
21,164
-2,866
-12% -$168K 0.32% 67
2016
Q3
$1.43M Buy
24,030
+738
+3% +$43.2K 0.39% 59
2016
Q2
$1.28M Sell
23,292
-2,665
-10% -$142K 0.39% 55
2016
Q1
$1.31M Buy
25,957
+1,538
+6% +$75.3K 0.33% 64
2015
Q4
$1.23M Buy
24,419
+542
+2% +$27.3K 0.33% 63
2015
Q3
$1.13M Buy
23,877
+2,303
+11% +$122K 0.32% 65
2015
Q2
$1.17M Buy
21,574
+1,686
+8% +$94.6K 0.33% 71
2015
Q1
$1.09M Sell
19,888
-540
-3% -$30.6K 0.3% 74
2014
Q4
$1.11M Hold
20,428
0.3% 74
2014
Q3
$1.16M Buy
20,428
+13
+0.1% +$730 0.33% 68
2014
Q2
$1.13M Buy
+20,415
New +$1.11M 0.33% 67

Other funds holding MRK

Ironsides Asset Advisors's MRK Position: Q1 2017 in Review

Ironsides Asset Advisors sold out of Merck (MRK) in Q1 2017, closing a stake of 21,164 shares — an estimated $1.19M sold.

Ironsides Asset Advisors first reported a position in MRK in Q2 2014 and held it in 11 quarters. The position peaked at $1.43M in Q3 2016. 1,941 funds tracked by Wall St. Rank hold MRK as of Q1 2017.

  • Ironsides Asset Advisors reported no remaining Merck position as of Q1 2017 after selling out during the quarter.
  • Ironsides Asset Advisors sold 21,164 Merck shares in Q1 2017, an estimated $1.19M.
  • Ironsides Asset Advisors first reported a position in Merck in Q2 2014 and held it in 11 quarters.
  • Ironsides Asset Advisors's Merck position peaked at $1.43M in Q3 2016.
  • 1,941 funds tracked by Wall St. Rank held Merck as of Q1 2017.

Based on Ironsides Asset Advisors's 13F filing for Q1 2017, filed 10 May 2017.